Re: Why now?
in response to
by
posted on
Jan 12, 2021 11:25AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I woke up this morning to see the TD revalued my Zenith shares to US .38 cents & reinserted the Tag ZCHLF in all my accounts.